HomeVIRP • EPA
add
Virbac SA
Previous close
€349.00
Day range
€350.00 - €358.50
Year range
€249.70 - €373.50
Market cap
2.97B EUR
Avg Volume
5.76K
P/E ratio
19.70
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 363.20M | 4.60% |
Operating expense | 190.96M | 0.91% |
Net income | 34.24M | 35.27% |
Net profit margin | 9.43 | 29.36% |
Earnings per share | — | — |
EBITDA | 66.79M | 26.31% |
Effective tax rate | 27.19% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.17M | -18.02% |
Total assets | 1.91B | 3.55% |
Total liabilities | 789.18M | -1.98% |
Total equity | 1.12B | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 6.36% | — |
Return on capital | 8.60% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 34.24M | 35.27% |
Cash from operations | 85.67M | 2.22% |
Cash from investing | -72.11M | -134.73% |
Cash from financing | -12.62M | 78.19% |
Net change in cash | 942.50K | -96.16% |
Free cash flow | 19.30M | 49.15% |
About
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 6th the largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
Founded
1968
Headquarters
Website
Employees
6,442
